Oncimmune® (USA) LLC Recognizes Lung Cancer Awareness Month; Featuring 30 Individual Lung Cancer Stories
De Soto, KS (PRWEB) November 07, 2011
Oncimmune (USA) LLC, maker of EarlyCDT®-Lung, a simple blood test that aids physicians in the early detection of lung cancer, is promoting Lung Cancer Awareness Month (LCAM) through an educational blog series. The series will feature 30 stories in 60 days from lung cancer survivors, those currently battling the disease and people who have lost loved ones to lung cancer.
Founded in 2006, Oncimmune (USA) LLC is committed to the ongoing pursuit of early cancer detection methods. Now offering the EarlyCDT-Lung test in all 50 states, Oncimmune is changing the way physicians approach lung cancer detection. EarlyCDT-Lung is a simple blood test used to identify specific autoantibodes (immuno-biomarkers), which are elevated in patients with lung cancer. Because these autoantibodies are present at the earliest stages of the disease, EarlyCDT-Lung can be used to aid in diagnosing high risk patients, potentially before they exhibit specific symptoms of lung cancer.
Observed during the month of November, LCAM is an annual educational campaign designed to raise awareness about the risk factors of lung cancer, detection methods, symptoms and available treatment options. During this annual observation, thought leaders in lung cancer research and education work together to foster conversation about this dangerous disease.
Oncimmune is doing their part to raise awareness during LCAM. The blog series was launched on Oncimmune’s educational website, http://www.HelloHaveYouHeard.com, on October 25. The 30 Stories in 60 Days series will run through mid-December. Each week the blog will feature stories of lung cancer survivors, as well as accounts from those who have lost loved ones to the disease.
One such story is of Sandra, a 66 year old lung cancer survivor. Sandra was a heavy smoker, but had stopped smoking in 2003. After suffering a continuous pain in her side, Sandra had a CT scan. The CT revealed a spot on her left lung. Her doctor recommended remaining vigilant with frequent follow-up imaging. While the spot on her lung was visible by CT, a PET scan did not reveal any signs of it being cancer.
Having lost her brother to the disease, this scare motivated Sandra to do more research. During her investigation she discovered Oncimmune’s Facebook page, and learned about EarlyCDT-Lung. Sandra decided to order an EarlyCDT-Lung collection kit and worked with her pulmonologist to have her blood drawn. The test results were positive, indicating that lung cancer might be present. After further evaluation, it turned out that Sandra had stage IA adenocarcinoma, predominantly bronchioloalveolar type.
Fortunately, her cancer had not spread to her lymph nodes and a thoracic surgeon was able to remove the tumor. In fact, just a couple weeks after Sandra’s surgery, she was back to teaching Zumba classes.
“We are honored to share these inspirational stories from some very strong individuals,” said Dan Calvo, President and CEO of Oncimmune. “Lung cancer has impacted my immediate family and I know that raising awareness about lung cancer through sharing of personal experiences is a valuable tool to fight and cope with this disease.”
In addition to the 30 Stories in 60 Days campaign, Oncimmune released an educational video series to promote LCAM. Each video provides insight and information to help the general public better understand the risks factors of lung cancer and the importance of early detection. Watch for more exciting announcements from Oncimmune as they work to educate the public about lung cancer during LCAM and throughout the year.
About Oncimmune LLC
Oncimmune (USA) LLC, founded in 2006, is an industry leader in early cancer detection. The company is committed to advancing early cancer detection through proprietary immuno-biomarker technologies based on biological technology identified by John Robertson, M.D., Professor of Surgery at Nottingham University, England, and Chief Scientific Officer of Oncimmune LTD. Ongoing research and development is conducted by Oncimmune under the direction of Professor Robertson. The company’s mission is to develop early cancer detection tests to identify more than 90% of solid-tumor cancers, which make up 70% of all cancers including lung, breast, colorectal, prostate, stomach, pancreatic and ovarian. All testing is performed exclusively at Oncimmune’s CLIA (Clinical Laboratory Improvement Act) regulated laboratory located in the metro Kansas City area. Oncimmune (USA) LLC is a wholly owned subsidiary of Oncimmune LTD. Oncimmune LTD owns a portfolio of patents, including Patent Nos. 7,402,403 and 7,205,117, with five others currently filed and under review. For more information about Oncimmune, visit: http://www.hellohaveyouheard.com.
###
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Treatment with the multitargeted agent vandetanib (Caprelsa) improved progression-free survival in patients with medullary thyroid cancer (MTC), according to findings from a randomized clinical trial. Earlier this year, the Food and Drug Administration (FDA) approved vandetanib for the treatment of patients with MTC based on initial findings from the phase III trial. MTC is a rare cancer, accounting for only 5 percent of all thyroid cancer cases, and radiation and chemotherapy have limited effects once the cancer progresses to an advanced stage.
NCI Cancer Bulletin
NY1 |
Evelyn H. Lauder Dies Of Non-Genetic Ovarian Cancer
Medical News Today
Evelyn Lauder, 75, founder of pink ribbon for cancer awareness, died today from complications of non-genetic ovarian cancer, which had been diagnosed in 2007, at her home in New York City, the Estée Lauder Companies Inc. (ELC) announced today. …
Breast Cancer Awareness Advocate Evelyn Lauder Dies At 75NY1
Creator of breast cancer's pink ribbon diesCBS News
Lauder, maker of breast cancer's pink ribbon, diesUSA Today
New York Times -Voice of America
all 511 news articles »
|
cancer – Google News
A few nice cancer Causes images I found:
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
Image by asterix611
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
Image by asterix611
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
Image by asterix611
STREET PROTEST: EXPOSURE TO ASBESTOS CAUSES CANCER – 42nd ST, cor 6th AVE, Manhattan NYC – 04/19/11
Researchers exploring why some women who take a common breast cancer drug develop serious joint pain have eliminated two possible causes: Inflammatory arthritis and autoimmune disease. Because of these findings, researchers say women should be encouraged to continue taking the medication to gain its full benefit.
ScienceDaily: Cancer News
Lavender Awareness CrossDesigned by one of our own, it is a Terra Sancta Guild exclusive!! Never before has a design been released that combines the aware…
Categories:
Cancer Caregiver Tags:
Breast, Cancer, causes, commonly, drugs, eliminate, helps, Joint, Linked, pain, Study, used
Scientists at the Helmholtz Zentrum München have played a major role in two studies that could fundamentally change the medical treatment of liver cancer. Doctors are now able to determine the degree of aggressiveness of the tumour in the early stages and can thus devise an individualised treatment plan…
Cancer / Oncology News From Medical News Today
Packaging Design Company, Flexpak Corporation, Walks to Support Breast Cancer Awareness
Packaging Design Company – Flexpak Corporation
Phoenix, AZ (PRWEB) November 08, 2011
On Saturday, October 29, 2011, packaging design company, Flexpak Corporation, had a team of over 20 walkers raise more than $ 1,100 through their participation in the 19th annual American Cancer Society’s, Making Strides Against Breast Cancer at Tempe Beach Park in Tempe, Arizona. This year’s three-mile walk, attended by the largest turnout in history with over 11,000 people raised an astounding $ 700,000! The Pink Walk was a celebration of survivorship, an occasion to express hope, and a shared goal to end a disease that threatens the lives of so many people we love.
“Flexpak has had a team of walkers the last 8 years,” said Wanda Guerra, Director of Finance and Flexpak team leader. “We had participation from every Flexpak department. What a great way to spend a Saturday with great weather, friends, exercise and all for a great cause! We give a special thanks to our team members who walked and to all who donated.”
Flexpak Corporation is proud to be a member of the Phoenix Valley contributing organizations that matched our individual Flexpak employee donations and proud to be a part of the American Cancer Society. More than a walk, the American Cancer Society Making Strides Against Breast Cancer is a powerful and inspiring event that unites communities to celebrate people who have battled cancer, raise awareness about the steps we can take to help prevent the disease, and raise money to find cures and support programs and services for those facing the disease.
The Flexpak Team’s fundraising support enables the American Cancer Society to save lives by:
Helping people stay well by educating and empowering women to live healthy lives and reduce their risk for breast cancer, and to get screening tests such as mammograms to find breast cancer early, when it is easiest to treat
Helping people facing breast cancer get well by providing information, day-to-day help, and emotional support to guide them through every step of their breast cancer experience
Finding cures by investing in and conducting research that leads to groundbreaking discoveries into breast cancer’s causes and cures
Fighting back by working with legislators to support laws that help fight breast cancer and help all women get access to screenings and care
In 2010, more than 800,000 walkers across the country joined the American Cancer Society in our united fight against breast cancer. Together, we raised more than $ 60 million through Making Strides events – and we did it one donation at a time.
About Flexpak Corporation
Since 1974, Flexpak Corporation has earned its world class reputation supplying custom thermoforming and contract packaging solutions to the most challenging packaging problems through award winning designs, value engineering analysis and outstanding productivity. Flexpak is committed to the highest standard of excellence in our products, services and performance.
Flexpak Corporation operates a fully integrated and registered ISO 9001:2008 manufacturing facility with such value-added services as design engineering, concept development, prototyping, tool fabrication, humidity and temperature controlled manufacturing environment, statistical analysis capabilities, part validations, and supply chain management, including extensive Maquiladora experience.
For more information about custom thermoforming and packaging design solutions, please visit http://www.flexpakcorp.com/.
###
Attachments
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Related Cancer Cure Press Releases
Radiation therapy after breast-conserving surgery substantially reduces the risk of cancer recurring in the breast and moderately reduces the risk of death from the disease, according to updated results from a meta-analysis by the Early Breast Cancer Trialists’ Collaborative Group.
NCI Cancer Bulletin
![]()
Presenting a multidisciplinary approach to cancer nursing, this edition includes new chapters on: cultural systems related to cancer; the burden of the caregiver; the principles of immunology; gene therapy; the physiological aspects of pain; pain assessment; pain management; confusion; current cancer nursing research; rehabilitation services; and the legal responsibility of the nurse. There is also a new unit on nurses’ personal experience with cancer, which covers areas such as managing cervical dysplasia, surviving breast cancer, living with the consequences of a spouse’s cancer, and recovering from the loss of a spouse.
List Price: $ 155.00
Price:
Psoriasin Multi-Symptom Psoriasis Relief Ointment, Intensive Moisturizing, 4 Ounces (Pack of 2)
Cancer: Symptoms & Treatment History (1940s) [DVD]
